Completed NA INTERVENTIONAL 2-arm NCT04304170

Dietary Supplementation Effects on Bowel Movement Frequency and Intestinal Biological Markers in Seniors Presenting Slowed Intestinal Transit

Randomized, Double-blind, Placebo-controlled Clinical Trial of the Effect of Dietary Supplementation With Bifidobacteria and Fructo-oligosaccharides (FOS) on Bowel Movement Frequency and Intestinal Biological Markers in Seniors Presenting Slowed Intestinal Transit

Sponsor: CEN Biotech

Conditions Constipation

Interventions Placebo VES002

Updated 4 times since 2020 Last updated: Mar 9, 2020 Started: Feb 21, 2017 Primary completion: Mar 15, 2018 Completion: Mar 15, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Constipation, this trial is completed. The trial is conducted by CEN Biotech and has accumulated 4 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CEN Biotech
Vesale Pharmaceutica

Data source: CEN Biotech

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dijon, France